Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC

Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy

Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling

Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer

Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)

CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2

A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

Combination Study With Soluble LAG-3 Fusion Protein Eftilagimod Alpha (IMP321) and Pembrolizumab in Patients With Previously Untreated Unresectable or Metastatic NSCLC, or Recurrent PD-X Refractory NSCLC or With Recurrent or Metastatic HNSCC

A Study of BGB324 in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer

MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC

Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer

Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer

MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors